New hope for advanced cancers? first human trial of PMC-309 begins
Disease control
Recruiting now
This early-stage study tests a new drug called PMC-309, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The main goal is to check safety and find the best dose. About 67 adults will take part.
Phase: PHASE1 • Sponsor: PharmAbcine • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC